Abstract |
The tetrahydrofuran (THF) containing annonaceous acetogenins (AAs) are attractive candidates for drug development because of their potent cytotoxicity against a wide range of tumors and their relatively simple and robust structures. Replacement of the THF segment with a sugar residue may deliver analogues with improved tumor selectivity and pharmacokinetics and are therefore attractive for drug development. As a first test to the feasibility of such structures, a set of such monosaccharide analogues was synthesized and assayed against four human tumor cell lines, cervical (HeLa), breast (MDA-MB231), T-cell leukemia (Jurkat) and prostate (PC-3). Certain analogues showed low micromolar activity that was comparable to a structurally similar, naturally occurring mono-THF acetogenin. A preliminary examination of the structure-activity profile of these carbohydrate analogues suggests that they have a similar mechanism of action as their THF congeners.
|
Authors | Stewart Bachan, K A Tony, Akira Kawamura, Diego Montenegro, Anjali Joshi, Himanshu Garg, David R Mootoo |
Journal | Bioorganic & medicinal chemistry
(Bioorg Med Chem)
Vol. 21
Issue 21
Pg. 6554-64
(Nov 01 2013)
ISSN: 1464-3391 [Electronic] England |
PMID | 24045006
(Publication Type: Journal Article, Research Support, N.I.H., Extramural)
|
Copyright | Copyright © 2013 Elsevier Ltd. All rights reserved. |
Chemical References |
- Acetogenins
- Antineoplastic Agents
- Carbohydrates
- Furans
- tetrahydrofuran
|
Topics |
- Acetogenins
(chemical synthesis, chemistry, toxicity)
- Antineoplastic Agents
(chemical synthesis, chemistry, toxicity)
- Carbohydrates
(chemistry)
- Cell Line, Tumor
- Cell Survival
(drug effects)
- Furans
(chemistry)
- HeLa Cells
- Humans
- Jurkat Cells
- Light
- Scattering, Radiation
- Stereoisomerism
- Structure-Activity Relationship
|